Quick Answer
BALCHEM CORP reported Cash and Equivalents of $74.57 million for fiscal year 2025.
BALCHEM CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $74.57M | +50.6% |
| 2024 | $49.52M | -23.2% |
| 2023 | $64.45M | -3.2% |
| 2022 | $66.56M | -35.5% |
| 2021 | $103.24M | +22.1% |
| 2020 | $84.57M | +28.8% |
| 2019 | $65.67M | +21.0% |
| 2018 | $54.27M | +34.3% |
| 2017 | $40.42M | +4.6% |
| 2016 | $38.64M | -54.4% |
| 2015 | $84.80M | +68.6% |
| 2014 | $50.29M | -75.9% |
| 2013 | $208.75M | +44.2% |
| 2012 | $144.74M | +26.1% |
| 2011 | $114.78M | +48.6% |
| 2010 | $77.25M | +66.4% |
| 2009 | $46.43M | +1256.9% |
| 2008 | $3.42M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $65.09M | -11.7% | -0.5% |
| June 30, 2025 | $65.43M | +2.6% | +31.1% |
| March 31, 2025 | $49.90M | -17.3% | +0.8% |
| December 31, 2024 | $49.52M | -23.2% | -32.8% |
| September 30, 2024 | $73.69M | -4.2% | +15.6% |
| June 30, 2024 | $63.74M | -4.7% | +5.6% |
| March 31, 2024 | $60.35M | +0.2% | -6.4% |
| December 31, 2023 | $64.45M | -3.2% | -16.3% |
- BALCHEM CORP showed an increase of +50.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, BALCHEM CORP’s cash and equivalents has grown by 2079.1% (from $3.42 million to $74.57 million).
- The most recent figure is from BALCHEM CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: